FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second Alzheimer s drug, lecanemab, despite reports of rare brain bleeds linked to use
FRIDAY, Jan. 6, 2023 (HealthDay News) The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds